| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.28B | 6.46B | 7.30B | 8.26B | 6.02B | 4.95B |
| Gross Profit | 14.28B | 6.46B | 4.04B | 3.63B | 4.61B | 4.15B |
| EBITDA | 7.28B | 2.35B | 1.06B | 1.15B | 4.82B | 4.34B |
| Net Income | 1.13B | -776.70M | -125.40M | -1.22B | 6.69B | 2.04B |
Balance Sheet | ||||||
| Total Assets | 111.40B | 113.96B | 113.82B | 113.25B | 120.31B | 70.34B |
| Cash, Cash Equivalents and Short-Term Investments | 19.93B | 15.14B | 14.70B | 20.36B | 10.90B | 7.90B |
| Total Debt | 9.03B | 8.68B | 24.76B | 24.55B | 29.50B | 19.92B |
| Total Liabilities | 42.37B | 48.19B | 46.42B | 45.04B | 46.46B | 21.37B |
| Stockholders Equity | 44.63B | 42.52B | 43.54B | 43.11B | 46.21B | 37.02B |
Cash Flow | ||||||
| Free Cash Flow | 5.21B | 6.79B | 1.03B | 12.28B | -1.11B | 2.22B |
| Operating Cash Flow | 5.41B | 7.04B | 1.24B | 12.39B | -1.00B | 2.29B |
| Investing Cash Flow | 77.30M | -1.19B | 3.38B | -4.51B | 2.55B | 1.09B |
| Financing Cash Flow | -5.30B | -5.19B | -1.11B | -5.99B | 490.30M | -2.56B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$3.46B | 6.57 | 11.00% | 6.92% | 4.78% | 24.02% | |
71 Outperform | HK$8.41B | 4.91 | 5.71% | 6.47% | 28.71% | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
60 Neutral | HK$10.57B | 20.99 | 11.99% | 3.17% | -2.45% | 71.08% | |
56 Neutral | HK$19.60B | 2.09 | 12.27% | 5.84% | 3.17% | 23.13% | |
54 Neutral | HK$34.53B | 8.52 | 7.50% | 6.69% | -1.77% | -24.74% | |
53 Neutral | HK$10.15B | 3.62 | 4.94% | ― | 99.58% | ― |